Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Operating Expenses (2010 - 2026)

Palatin Technologies' (PTN) quarterly Operating Expenses came in at $5.5 million in Q1 2026, up 14.3% on a YoY basis from $4.8 million in Q1 2025, and down 26.1% quarter-over-quarter from $7.4 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Operating Expenses (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Operating Expenses for 17 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 14.3% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.4 million (down 18.75% YoY), and the FY2025 full-year result was $17.5 million, down 35.3% from the prior year.
  • Operating Expenses retreated to $5.5 million in Q1 2026 per PTN's latest filing, from $7.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $13.9 million in Q2 2022 and bottomed at $860968.0 in Q4 2023.
  • Historically, Operating Expenses has averaged $7.1 million across 5 years, with a median of $7.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 86.98% in 2023, then surged 203.3% in 2024.
  • Over 5 years, Operating Expenses stood at $6.6 million in 2022, then sank by 86.98% to $860968.0 in 2023, then soared by 203.3% to $2.6 million in 2024, then jumped by 185.09% to $7.4 million in 2025, then decreased by 26.1% to $5.5 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $5.5 million, $7.4 million, and $4.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 367.83 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 5.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.50 Mn
Dec 31, 2025 7.44 Mn
Sep 30, 2025 4.19 Mn
Jun 30, 2025 2.27 Mn
Mar 31, 2025 4.81 Mn
Dec 31, 2024 2.61 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 8.69 Mn
Mar 31, 2024 9.22 Mn
Dec 31, 2023 860,968.00
Sep 30, 2023 8.21 Mn
Jun 30, 2023 12.58 Mn
Mar 31, 2023 8.50 Mn
Dec 31, 2022 6.61 Mn
Sep 30, 2022 9.62 Mn
Jun 30, 2022 13.87 Mn
Mar 31, 2022 8.04 Mn
Dec 31, 2021 8.77 Mn
Sep 30, 2021 7.38 Mn
Jun 30, 2021 13.88 Mn